Eurlings Irene M J, Reynaert Niki L, van de Wetering Cheryl, Aesif Scott W, Mercken Evi M, de Cabo Rafael, van der Velden Jos L, Janssen-Heininger Yvonne M, Wouters Emiel F M, Dentener Mieke A
1 Department of Respiratory Medicine, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands.
2 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Am J Respir Cell Mol Biol. 2017 Mar;56(3):393-401. doi: 10.1165/rcmb.2015-0195OC.
Lung tissue remodeling in chronic obstructive pulmonary disease (COPD) is characterized by airway wall thickening and/or emphysema. Although the bronchial and alveolar compartments are functionally independent entities, we recently showed comparable alterations in matrix composition comprised of decreased elastin content and increased collagen and hyaluronan contents of alveolar and small airway walls. Out of several animal models tested, surfactant protein C (SPC)-TNF-α mice showed remodeling in alveolar and airway walls similar to what we observed in patients with COPD. Epithelial cells are able to undergo a phenotypic shift, gaining mesenchymal properties, a process in which c-Jun N-terminal kinase (JNK) signaling is involved. Therefore, we hypothesized that TNF-α induces JNK-dependent epithelial plasticity, which contributes to lung matrix remodeling. To this end, the ability of TNF-α to induce a phenotypic shift was assessed in A549, BEAS2B, and primary bronchial epithelial cells, and phenotypic markers were studied in SPC-TNF-α mice. Phenotypic markers of mesenchymal cells were elevated both in vitro and in vivo, as shown by the expression of vimentin, plasminogen activator inhibitor-1, collagen, and matrix metalloproteinases. Concurrently, the expression of the epithelial markers, E-cadherin and keratin 7 and 18, was attenuated. A pharmacological inhibitor of JNK attenuated this phenotypic shift in vitro, demonstrating involvement of JNK signaling in this process. Interestingly, activation of JNK signaling was also clearly present in lungs of SPC-TNF-α mice and patients with COPD. Together, these data show a role for TNF-α in the induction of a phenotypic shift in vitro, resulting in increased collagen production and the expression of elastin-degrading matrix metalloproteinases, and provide evidence for involvement of the TNF-α-JNK axis in extracellular matrix remodeling.
慢性阻塞性肺疾病(COPD)中的肺组织重塑表现为气道壁增厚和/或肺气肿。尽管支气管和肺泡腔是功能上独立的实体,但我们最近发现,肺泡和小气道壁的基质组成存在类似变化,包括弹性蛋白含量降低、胶原蛋白和透明质酸含量增加。在测试的几种动物模型中,表面活性蛋白C(SPC)-TNF-α小鼠的肺泡和气道壁出现了类似于我们在COPD患者中观察到的重塑。上皮细胞能够发生表型转变,获得间充质特性,这一过程涉及c-Jun氨基末端激酶(JNK)信号传导。因此,我们推测TNF-α诱导JNK依赖的上皮可塑性,这有助于肺基质重塑。为此,在A549、BEAS2B和原代支气管上皮细胞中评估了TNF-α诱导表型转变的能力,并在SPC-TNF-α小鼠中研究了表型标志物。间充质细胞的表型标志物在体外和体内均升高,波形蛋白、纤溶酶原激活物抑制剂-1、胶原蛋白和基质金属蛋白酶的表达表明了这一点。同时,上皮标志物E-钙黏蛋白、角蛋白7和18的表达减弱。JNK的药理学抑制剂在体外减弱了这种表型转变,表明JNK信号传导参与了这一过程。有趣的是,JNK信号传导的激活在SPC-TNF-α小鼠和COPD患者的肺中也明显存在。总之,这些数据表明TNF-α在体外诱导表型转变中起作用,导致胶原蛋白产生增加和弹性蛋白降解基质金属蛋白酶的表达,并为TNF-α-JNK轴参与细胞外基质重塑提供了证据。